Intrabody Selection and Validation
Release time:
2023-04-16
Our intrabodies represent functional intracellular nanobodies expressed and properly folded in the cell cytoplasm where they recognize their endogenous target.
To enrich for intrabodies, we combine classical Phage Display Screening with our expertise in Yeast Two-Hybrid screening. These functional nanobodies are expressed inside the cell where they target endogenous antigen.
This combined strategy is useful for VHH selection against soluble antigens that are particularly difficult to express or purify in heterologous expression systems.
Key benefits
● Enrichment of intracellular targeting nanobodies
● No batch-to-batch variability
Related News
2023-12-10
Targeting Protein-Protein Binding for Therapeutic Development: Unlocking the Potential of Biologics
2023-12-10
Understanding Protein Protein Binding and Its Significance in Medicine
2023-12-10
Understanding Protein Protein Binding: A Comprehensive Guide
2023-12-10
The Role of Protein Protein Binding in Drug Discovery: A Comprehensive Guide
2023-12-10
2023-12-09
Unveiling the Secrets of Protein-Protein Interaction: A Breakthrough Study
2023-12-09
2023-12-09